NCT03297424 - A Study of PLX2853 in Advanced Malignancies. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

June 7, 2021

Study Completion Date

June 7, 2021

Conditions

Small Cell Lung CancerUveal MelanomaOvarian Clear Cell CarcinomaNon-Hodgkin LymphomaAdvanced MalignanciesSolid TumorDiffuse Large B Cell LymphomaFollicular Lymphoma

Interventions

DRUG

PLX2853

tablets

Trial Locations (5)

10032

Columbia University Medical Center, New York

22031

Virginia Cancer Specialists, Fairfax

33136

Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine, Miami

78229

South Texas Accelerated Research Therapeutics (START), San Antonio

85258

Honor Health, Scottsdale